Vancouver, BC — TheNewswire — June 25, 2026 — Metasphere Labs Inc. (CSE: LABZ) (OTC Pink: LABZF) (FRA: H1N) ("Metasphere" or the "Company") is pleased to announce a non-brokered private placement (the “Offering”) of up to 3,571,429 units of the Company (each, a “Unit”) at a price of $0.14 per Unit, for gross proceeds of up to $500,000.

Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share at a price of $0.175 per Common Share for a period of 48 months from the date of issuance.

The net proceeds from the Offering will be used for general and administrative expenses and working capital.

The Offering may close in one or more tranches and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval of the CSE. The Company may pay finder’s fees and/or issue finder’s warrants in connection with the Offering in accordance with applicable securities laws and CSE policies.

All securities issued pursuant to the Offering will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable Canadian securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.

The securities issued under the Offering have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.

Change of Corporate Secretary

The Company also announces the appointment of Elijah Dumaresq as Corporate Secretary of the Company, effective June 18, 2026. This appointment follows Francis Rowe's resignation from the Corporate Secretary role; Mr. Rowe continues in his capacity as Chief Financial Officer of the Company.

Mr. Dumaresq currently serves as an executive officer of Zefiro Methane Corp., where he previously held the position of Chief Financial Officer from January 2020 to March 2024. Prior to joining Zefiro, His career encompasses roles in private equity, investment management. In his current capacity, Elijah assists with financial strategy, manages regulatory compliance, and oversees corporate governance. As CFO of Zefiro Methane Corp., he oversaw all aspects of financial management and played a pivotal role in taking the company public. Over the course of Mr. Dumaresq’s career he has served as an officer of several public companies listed in both the U.S and Canada.

Elijah Dumaresq is an honors graduate in Economics from McGill University.

About Metasphere Labs Inc.

Metasphere Labs Inc. specializes in integrating blockchain technology into real-world applications, with a focus on environmental sustainability and social impact.

For more information, please contact:
Metasphere Labs Inc.
Francis Rowe, CFO
Email: info@metasphere.earth

Phone: 604-687-2038

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

 

This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including statements regarding the proposed Offering, the anticipated use of proceeds, the number of Units to be issued, the anticipated closing of the Offering, the potential payment of finder's fees and issuance of finder's warrants, and the receipt of regulatory approvals, including CSE approval. Forward-looking information is based on the reasonable assumptions, estimates, internal forecasts, and expectations of the Company's management at the time such information is made. Such assumptions include, without limitation, that the Offering will close on the anticipated terms, that CSE approval will be obtained, and that market and economic conditions will remain favourable to the completion of the Offering.

Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to differ materially from those expressed or implied, including the risk that the Offering does not close on the anticipated terms or at all, failure to obtain required regulatory approvals, changes in market conditions, and general economic, market, or business conditions. There can be no assurance that any forward-looking information will prove to be accurate, and readers are cautioned not to place undue reliance on forward-looking information.

The Company does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.